239 related articles for article (PubMed ID: 21389124)
1. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
Liu KH; Ascenzi MA; Bellezza CA; Bezuidenhout AJ; Cote PJ; Gonzalez-Aseguinolaza G; Hannaman D; Luxembourg A; Evans CF; Tennant BC; Menne S
J Virol; 2011 May; 85(10):4853-62. PubMed ID: 21389124
[TBL] [Abstract][Full Text] [Related]
2. Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.
Cote PJ; Butler SD; George AL; Fairman J; Gerin JL; Tennant BC; Menne S
J Med Virol; 2009 Oct; 81(10):1760-72. PubMed ID: 19697409
[TBL] [Abstract][Full Text] [Related]
3. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.
Lu M; Hilken G; Kruppenbacher J; Kemper T; Schirmbeck R; Reimann J; Roggendorf M
J Virol; 1999 Jan; 73(1):281-9. PubMed ID: 9847331
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.
Luxembourg A; Hannaman D; Wills K; Bernard R; Tennant BC; Menne S; Cote PJ
Vaccine; 2008 Jul; 26(32):4025-33. PubMed ID: 18556096
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
[TBL] [Abstract][Full Text] [Related]
6. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
Lu M; Isogawa M; Xu Y; Hilken G
J Virol; 2005 May; 79(10):6368-76. PubMed ID: 15858020
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model.
Lu M; Roggendorf M
Intervirology; 2001; 44(2-3):124-31. PubMed ID: 11509873
[TBL] [Abstract][Full Text] [Related]
8. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
[TBL] [Abstract][Full Text] [Related]
9. Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.
Lu M; Klaes R; Menne S; Gerlich W; Stahl B; Dienes HP; Drebber U; Roggendorf M
J Hepatol; 2003 Sep; 39(3):405-13. PubMed ID: 12927927
[TBL] [Abstract][Full Text] [Related]
10. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.
Siegel F; Lu M; Roggendorf M
J Virol; 2001 Jun; 75(11):5036-42. PubMed ID: 11333883
[TBL] [Abstract][Full Text] [Related]
11. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
Wang J; Gujar SA; Cova L; Michalak TI
J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
[TBL] [Abstract][Full Text] [Related]
12. DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.
Kosinska AD; Johrden L; Zhang E; Fiedler M; Mayer A; Wildner O; Lu M; Roggendorf M
J Virol; 2012 Sep; 86(17):9297-310. PubMed ID: 22718818
[TBL] [Abstract][Full Text] [Related]
13. Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.
Kosinska AD; Zhang E; Johrden L; Liu J; Seiz PL; Zhang X; Ma Z; Kemper T; Fiedler M; Glebe D; Wildner O; Dittmer U; Lu M; Roggendorf M
PLoS Pathog; 2013; 9(6):e1003391. PubMed ID: 23785279
[TBL] [Abstract][Full Text] [Related]
14. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Korba BE; Gerin JL; Tennant BC; Cote PJ
J Virol; 2002 Jun; 76(11):5305-14. PubMed ID: 11991959
[TBL] [Abstract][Full Text] [Related]
15. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.
Menne S; Maschke J; Tolle TK; Lu M; Roggendorf M
J Virol; 1997 Jan; 71(1):65-74. PubMed ID: 8985324
[TBL] [Abstract][Full Text] [Related]
16. Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.
Glebe D; Lorenz H; Gerlich WH; Butler SD; Tochkov IA; Tennant BC; Cote P; Menne S
J Virol; 2009 Feb; 83(4):1579-91. PubMed ID: 19052077
[TBL] [Abstract][Full Text] [Related]
17. Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids.
Chen H; Wen B; Deng Y; Wang W; Yin X; Guan J; Ruan L; Tan W
Clin Vaccine Immunol; 2011 Nov; 18(11):1789-95. PubMed ID: 21900535
[TBL] [Abstract][Full Text] [Related]
18. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
Korba BE; Cote PJ; Menne S; Toshkov I; Baldwin BH; Wells FV; Tennant BC; Gerin JL
Antivir Ther; 2004 Dec; 9(6):937-52. PubMed ID: 15651753
[TBL] [Abstract][Full Text] [Related]
19. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
Hervás-Stubbs S; Lasarte JJ; Sarobe P; Vivas I; Condreay L; Cullen JM; Prieto J; Borrás-Cuesta F
J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
[TBL] [Abstract][Full Text] [Related]
20. DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.
Yin Y; Wu C; Song J; Wang J; Zhang E; Liu H; Yang D; Chen X; Lu M; Xu Y
PLoS One; 2011; 6(7):e22524. PubMed ID: 21799884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
